)
)
)
Astria Therapeutics
Astria Therapeutics has entered into an agreement to be acquired by BioCryst Pharmaceuticals, who are focused on developing therapies for rare diseases. Astria's POC-ready STAR-0310 for the treatment of atopic dermatitis and a range of other immunological disorders is non-core to BioCryst's corporate strategy, and we seek strategic partners for externalization of the program.
Address
BostonMassachusetts
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)